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Summary The affects of L-thyroxine (T4) on the incidence and histology of gastric cancers induced by
N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), and on the labelling index of gastric mucosal epithelial cells
were investigated in Wistar rats. After oral treatment with MNNG for 25 weeks, the rats received s.c.
injections of T4 (0.2 jug kg-') in depot form every other day until the end of the experiment in Week 52. This
long-term treatment with T4 significantly increased the incidence of gastric cancers in Week 52. However, it did
not influence the histological type of the gastric cancers. It also caused significant increases in the labelling
indices of the fundic and antral epithelial cells. These findings indicate that T4 enhances the development of
gastric cancers, and that its effect may be related to its effect in increasing proliferation of gastric epithelial
cells.
Thyroid hormones have important regulatory roles in the
morphology and biochemistry of gastrointestinal mucosal
cells (Hernandez et al., 1988). Long-term T4 administration
increased the mitotic activity of the fundic 'stem' cells of the
stomach and basal and secretagogue-stimulated acid secre-
tion via its effect on parietal cell mass (Adeniyi &
Olowookorun, 1989). We recently found that prolonged
administration of T4 significantly increased the incidence of
rat colon tumours induced by azoxymethane (Iishi et al.,
1992). These findings suggest that T4 might influence gastric
carcinogenesis. Therefore, in the present work, we examined
the effect of treatment of rats with T4 on the development of
gastric cancers in rats.
Materials and methods
Animals
Sixty 6-week-old male Wistar rats (SLC, Shizuoka, Japan)
were used in this study. They were housed in stainless steel
suspended wire mesh cages, under controlled environmental
conditions of 12 h light and 12 h darkness, 30-50%
humidity, and 21-22'C. Each rat was given standard
laboratory chow (Oriental Yeast, Tokyo, Japan) at 60 kcal
per day.
Experimental design
The animals were given drinking water containing MNNG
(25 ytg ml-'; Aldrich, Milwaukee, WI) for 25 weeks. The
stock solution of MNNG was prepared at 1 mg ml1' in
deionised water and kept in a cool, dark place and renewed
every week. Just before administration to rats it was diluted
to 25 tg ml-' with tap water. Rats were given 20 ml per day
of MNNG solution each, supplied from bottles covered with
aluminium foil to prevent photolysis of MNNG, and the
solution was renewed every other day. Safety precautions
were taken in use of MNNG. From Week 26, the rats were
given normal tap water ad libitum and were randomly
divided into two groups of 30 rats each. Group 1 was given
s.c. injections of the vehicle, plain olive oil only, while Group
2 was given s.c. injections of T4 in depot form (Sigma, St.
Louis, MO, USA; 0.2 jig kg-' body weight) in olive oil until
Week 52. Injections were given at various sites every other
day in a volume of 1 ml kg-' body weight between 2 and 3
p.m.
Tissue sampling
Animals that survived for more than 49 weeks were included
in effective numbers, because the first tumour of the glan-
dular stomach was found in a rat in Group 2 that died in
Week 49. All surviving animals were killed at the end of the
experiment in Week 52. All rats were autopsied, and the
stomach and other organs were carefully examined. The
stomach was opened along the greater curvature, pinned flat
on a cork mat, and fixed in Zamboni's solution (Stefanini et
al., 1967) for histological examination. The fixed stomach
was cut into longitudinal, 3 mm wide strips. The specimens
were embedded in paraffin, and 5 gm thick serial sections
were stained with hematoxylin and eosin. Sections were
examined without knowledge of which group they were
from.
Classification ofgastric cancers
Histologically, adenocarcinomas were defined as lesions in
which neoplastic cells had penetrated the muscularis mucosae
to the submucosa or deeper layers. Adenocarcinomas were
classified as very well-differentiated, well-differentiated, and
poorly differentiated, as reported previously (Tatsuta et al.,
1988b). Very well-differentiated adenocarcinoma: cancers
showing atypical glandular structure with a tubular or papil-
lary pattern and an arrangement of cells comparable to that
enclosing normal gastrointestinal crypts (Figure la). Well-
differentiated adenocarcinoma: common type, less differenti-
ated glands consisting of disorderly masses of atypical cells
containing a small amount of intracellular mucin (Figure lb);
mucinous carcinoma, active mucin secretion, often resulting
in mucinous nodules with a large amount of extracellular
mucin, with only a few isolated groups of tumour cells
(Figure Ic). Poorly differentiated adenocarcinoma: anaplastic
carcinoma, highly anaplastic cells scattered individually with
no typical glandular or tubular differentiation; signet-ring cell
carcinoma, tumour cells with a large amount of intracellular
mucin, giving the cells a signet-ring appearance (Figure
Id).
Measurement oflabelling index ofgastric mucosa
Five rats in each group were killed in experimental Weeks 30
and 52 to determine the labelling index of the gastric mucosa
with an immunohistochemical analysis kit (Becton-
Dickinson, Mountain View, CA) for assay of bromodeoxy-
uridine (BrdU) incorporation (Gratzner, 1982; Morstyn et
al., 1983). For this purpose, the rats were starved for 12 h
and then received s.c. injection of either 1 ml kg-' of olive oil
(Group 1) or 0.2 tLg kg-' of T4 (Group 2). One hour later,
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the animals received an i.p. injection of BrdU (20 mg kg-'),
and after another hour were killed with ether. The stomach
was removed and fixed in 70% ethanol for 4 h. Sections of
3 ltm thickness were immersed in 2 N HCI solution for 30 min
at room temperature, and then in 0.1 M Na2B407 to neutralise
the acid. The sections were then stained with anti-BrdU
monoclonal antibody (diluted 1:100) for 2 h at room
temperature, washed, treated with biotin-conjugated horse
anti-mouse antibody (at 1:200 dilution) for 30 min, and
stained with avidin-biotin-peroxidase complex for 30 min.
The reaction product was localised with 3,3'-diamino-
benzidine tetrahydrochloride. Cells containing BrdU were
identified by the presence of dark pigment over their
nucleus.
The labelling index of the gastric mucosa were determined
by counting BrdU-labelled and unlabelled cells in the zone of
proliferating cells (Eastwood & Quimby, 1983) without
knowledge of which group the sample was from. The zone of
proliferating cells in the fundic mucosa was defined as a
250-iLm rectangular area between the highest and lowest
labelled cells in well-oriented sections. Ten such rectangular
areas in each rat were examined. In the antral mucosa, all
cells below the highest labelled cells in each pit-gland column
were regarded as being within the zone of proliferating cells.
In each rat, 100 well-oriented columns of pits and glands
were examined, and the labelling index was calculated as the
number of BrdU-labelled cells/total number of cells within
the zone of proliferating cells.
Measurements ofserum T4 and T3
Serum T4 and triiodothyronine (T3) were measured in Weeks
30 and 52. For this purpose, five rats in each group were
kept for 12 h without food, and then received an s.c. injec-
tion of either 1 ml kg- ' of olive oil (Group 1) or 0.2 tLg kg-
of T4 (Group 2). Two hours later, they were anesthetised
with ether and blood was obtained by cardiac puncture. The
serum was separated and stored at - 20°C. Within 1 week,
the serum T4 and T3 were assayed with commercial radioim-
munoassay kits (Gamma Coat T4 RIA kit and Gamma Coat
T3 RIA kit).
Statistical analysis
Incidence and distribution of the different histological types
of gastric cancers were analysed by the chi-square test or
Fisher's exact probability test (Siegel, 1956). Other results
were all analysed by one-way analysis of variance with Dunn's
multiple comparison (Snedecor & Cochran, 1967; Miller,
1966). Data are shown as mean ± s.e.m. 'Significant'
indicates a calculated P value of less than 0.05.
Results
Incidence and histological type ofgastric cancer
The body weight, food consumption and incidence, numbers
and histological types of gastric cancers in each group are
summarised in Table I. In Week 52, animals that received T4
(Group 2) had significantly lower body weights than un-
treated rats. Table I also shows that there were no significant
differences between the food consumption in the two groups
in Weeks 30 and 45. In Group 1 (olive oil), four gastric
cancers were found in four (20%) of 20 rats examined. In
Group 2 (T4), 12 gastric cancers were found in 11 (55%) of
20 rats examined. The incidence of gastric cancers in Group
2 was significantly greater than that in Group 1. All the
tumours induced in the glandular stomach were identified
histologically as adenocarcinomas. Almost all were very well-
differentiated, and neither mucinous carcinomas or poorly
differentiated cancers were found in this series. There was no
significant difference in the histological types of adenocar-
cinomas in the two groups: all cancers in Group 1 were very
well-differentiated, while in Group 2 very well-differentiated
adenocarcinomas were found in 11 (92%) of 12 tumours and
the other was well-differentiated. All cancers were found in
the antral mucosa, and no metastases were detected at the
macroscopic and/or microscopic level.
Labelling index ofgastric mucosa and serum 14 and T3 levels
Table II summarises data on the labelling indices of gastric
mucosa in Weeks 30 and 52. At both times, Group 2 (T4)
showed significantly higher labelling indices and increased
number of cells in the zone of proliferating cells in both the
fundic and antral mucosa than Group 1 (olive oil). Table III
shows that at both times, administration of T4 significantly
increased the serum levels of T4 and T3.
Discussion
In the present work, we found that T4 enhanced gastric
carcinogenesis induced by MNNG in Wistar rats. Long-term
s.c. administration of T4 in depot form significantly increased
the incidence of gastric cancer, but had no influence on their
histological type at autopsy in Week 52.
Table I Incidences and numbers of gastric cancers in MNNG-treated rats
No. of
Effective rats with No. of
Group Body weight (g) Food intake (glday) no. of gastric gastric
no. Treatmenta 26W 52W 30W 45W rats cancer (%) cancers
I Olive oil 319±4 379±6 21 1 21 1 20 4 (20) 4
2 T4 320±5 331±5c 19±1 20±1 20 11 (55)b 12
aTreatment: Rats were given drinking water containing MNNG for 25 weeks, and then received
s.c. injections of the vehicle, olive oil (Group 1) or 0.2 jigkg-' of thyroxine (T4) in depot form
(Group 2) every other day until the end of the experiment in week 52. b,CSignificance of difference
from the value in Group 1: bp <0.05, CP<0.001.
Table II Epithelial proliferation of gastric mucosa in MNNG-treated rats
Fundic mucosa Antral mucosa
No. of No. of
Experi- No. of cells in Labelling No. of cells in Labelling
mental Group labelled prolife- index labelled prolife- index
week no. Treatmenta cells rating zone (%) cells rating zone (%)
30 1 Olive oil 19.6± 2.4 185.4± 24.4 10.8 ± 1.1 2.6± 0.3 13.6± 0.6 20.2± 1.0
2 T4 80.6 ± 4.0d 364.0 ± 35.6c 22.8 ± 2.0d 5.0 ± 0.4c 19.0 ± 1.0b 28.0 ± 1.6c
52 1 Olive oil 17.8 2.3 180.4 30.0 10.2 0.9 2.9 0.2 16.1 ± 1.7 18.2 ± 1.1
2 T4 84.6 + 69d 356.4 + 35.9C 24.4 + 2.7c 6.6 0.5d 23.3 ± 0.9c 28.2 ± 1.6d
aFor explanation of treatments, see Table I. b-dSignificance of difference from the value in Group 1: bp<0.05. cp<00.l, dp<O.OOl.ENHANCEMENT OF GASTRIC CARCINOGENESIS BY T4 517
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Figure 1 Histological classification of gastric adenocarcinomas in MNNG-treated rats. a, very well-differentiated adenocarcinoma:
b, common type of well-differentiated adenocarcinoma: c, mucinous well-differentiated adenocarcinoma: d, signet-ring cell car-
cinoma. H & E, x 200. Bars, 100 rim.
Table III Serum T4 and T3 levels in MNNG-treated rats
Thyroid hormone
Experimental Group T4 T3
week no. Treatmenta (1tgdl-') (ngml-')
30 1 Olive oil 1.9±0.1 0.4 0.0
2 T4 16.0 l.lb 2.0 o.ob
52 1 Olive oil 1.8±0.1 0.4 0.0
2 T4 17.0+ 1.3b 2.2+0.2b
aFor explanation of treatments, see Table I. bSignificance of
difference from the value of Group 1 at P <0.001.
The mechanism of this effect is not known, but three
possible explanations may be considered. One is an
immunomodulatory role of T4. Thyroid hormones have
immunostimulatory (Pierpaoli et al., 1969; Bachman &
Marshaly, 1986) and immunosuppressive (Gupta et al., 1983)
effects on the lymphocyte population. As observed after
other endocrine treatments, e.g., with estrogen or cortisone in
mice (Milisauskas et al., 1983; Hochman & Cudkowicz,
1979), the inhibition of natural killer cell activity caused by
long-term T4 administration might be ascribed to the induc-
tion of suppressor cells.
A second possibility is an influence of T4 on the secretion
and/or synthesis of regulatory peptides such as epidermal
growth factor (EGF) and somatostatin. Walker et al. (1981)
found that 5 and 10 days treatments with T4 significantly
increased the EGF concentration in the submaxillary gland
of mice. EGF is a well characterised polypeptide that exhibits
mitogenic effects on a wide range of cell types after binding
to specific transmembrane receptors (Cohen, 1983). As EGF
can stimulate mucosal growth throughout the gastrointestinal
tract, it has been suggested as playing a role in gastrointes-
tinal carcinogenesis. Yasui et al. (1990) found that prolonged
s.c. administration of EGF significantly increased the
incidence of gastric cancers induced by MNNG. A high level
of T4 was shown to increase the secretion and hypothalamic
content of somatostatin in vivo and in vitro (Berelowitz et al.,
1980). We found previously that prolonged s.c. administra-
tion of somatostatin significantly increased the incidence and
number of gastric cancers (Tatsuta et al., 1989).
A third possibility is an acceleration of cell proliferation by
T4. de Launoit and Kiss (1989) found that T4 dramatically
stimulated the cell division by MXT (mouse) and MCF-7
(human) mammary cancer cell lines. In mammary tumori-
genesis, T4 may exert its stimulatory effect at the level of the
nuclear chromatin receptors (Oppenheimer, 1979). In the
present work, we found that administration of T4
significantly increased the number of cells in the zone of
proliferating cells and the labelling index of the antral and
fundic epithelial cells.
Adeniyi and Olowookorun (1989) found that chronic T4
administration significantly increased the mucosal thickness
and volume, the parietal cell count per unit mass of the
glandular stomach. However, they did not examine the
effects of T4 on the antral mucosa. Recently, we examined
the effects of long-term administration of T4 for 20 weeks on
the fundic and antral mucosa in rats without MNNG
pretreatment and found that T4 significantly increased the
labelling indices in both the antral (25.0± 1.1 vs
16.6 1.4%, P<0.01) and the fundic (17.8 1.1 vs
10.4 0.5%, P<0.001) mucosa, compared to those in con-
trol group. However, we observed neither significant
differences between the average heights of the antral and
fundic mucosa in the two groups nor mucosal dysplasia
h
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associated with T4 treatment in non-carcinogen treated
rats.
The present study showed that T4 administration increased
the yield of gastric cancers after MNNG treatment,
presumably by acting as a non-genotoxic growth stimulator
for the mucosal cells. Watanabe et al. (1992) found that oral
administration of NaCl after MNNG pretreatment
significantly increased the incidence of gastric cancers and
that it also significantly increased the height of the pyloric
mucosa. Many investigators (Takahashi et al., 1986; Tatsuta
et al., 1988a; Kobori et al., 1984) have indicated that enhanc-
ing effects on gastric carcinogenesis may be related to
stimulation of cell proliferation and elongation of the
mucosa. These findings suggest that a non-genotoxic compo-
nent increases tumour yield when administered subsequent to
a genotoxic agent.
Abbreviations:
MNNG, N-methyl-N'-nitro-N-nitrosoguanidine; BrdU, bromodeoxy-
uridine; T4, L-thyroxine; T3, triiodothyronine; EGF, epidermal
growth factor.
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